1Chugh SS. Early identification of risk factors for sudden cardiac death[J]. Rev Cardiol,2010,7(6) :318-326.
2Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management[J]. Mayo Clin Proc,2009,84(10):917-938.
3Thygesen K, Alpert JS, White HD. Universal definition of myo- cardial infarction[J]. J Am Coil Cardiol,2007,50(22) :2173-2195.
4Cummins B, Auckland ML,Cummins P. Cardiac specific troponin- I radioimmunoassay in the diagnosis of acute myocardial infarction [J].J Am Heart,1987,113(6):1333-1344.
5Katus ttA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiactroponin T [J]. Clin Chem. 1992,38(3) :386-393.
6Muller Bardoff M, Hallerrnayer K, Schroder A, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation[J]. Clin Chem, 1997,43(3) :458-466.
7Nagesh CM,Roy A. Role of biomarkers in risk stratification of a-cute coronary syndrome[J]. Indian J Med Res, 2010,132 ( 5 ): 627- 633.
8Keller T,Zeller T,Peetz D,et al. Sensitive troponin I assay in ear- ly diagnosis of acute myocardial infarction[J]. N Engl J Med, 2009,361(9) :868-877.
9de Zoysa JR. Cardiac troponins and renal disease[J]. Nephrology (Carlton), 2004,9 : 83-88.
10Chan CP,Sanderson JE,Glatz JF, et al. A superior early myocardial infarction marker. Human heart-type fatty acid-binding pro- tein[J]. Z Kardiol,2004,93(5) :388-397.
5Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, et al. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease[J]. Am J Med, 2004, 116 (6):429-430.
6Pecoits-Filho R,Stenvinkel P,Marchlewska A,et al. Afunctional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients[J]. Kidney Int Suppl, 2003, 84:172- 176.
7Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum level predict risk in patients with acute coronary syndromes[J]. Circulation, 2003, 108:1440-1445.
8Kiffmeyer WR, Langer E, Davies SM, et al. Genetic polymorphisms in the Hmong population: implications for cancer etiology and survival[J]. Cancer, 2004, 100(2) :411.
9Kantarci OH, Lesnick TG, Yang P, et al. Myeloperoxidase-468 (G> A) polymorphism associated with lower risk of lung cancer[J]. Mayo Clin Proc, 2002, 77(1):17.
10Feyler A, Voho A, Bouchardy C, et al. Point myeloperoxidase-463G-> A polymorphism and lung cancer risk [J]. Cancer Epidemiol Biomarkers Prey, 2002, 11 (12) : 1550.
